Nuria M. Mendiola-Rodriguez - Publications

Incremental hemodialysis and vascular access complications: a 12-year experience in a hospital hemodialysis unit.

Journal: Journal of nephrology

Published: December 15, 2023

Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy.

Journal: Kidney360

Published: December 02, 2022

Individually adjusted absolute blood volume feedback control: A promising solution for intradialytic hypotension.

Journal: Hemodialysis international. International Symposium on Home Hemodialysis

Published: August 26, 2022

Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy.

Journal: Clinical kidney journal

Published: February 01, 2022

Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 27, 2021

Comparison of 3 anti-PLA2R inmmunoassaysfor the diagnosis of idiopathic membranous nephropathy in an european population. A pilot study.

Journal: Clinical immunology (Orlando, Fla.)

Published: January 21, 2021

Effect of oral administration of docohexanoic acid on anemia and inflammation in hemodialysis patients: A randomized controlled clinical trial.

Journal: Clinical nutrition ESPEN

Published: December 11, 2020

Validation of a Histologic Scoring Index for C3 Glomerulopathy.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: April 24, 2020

Percutaneous Renal Biopsy Prescreen Prior to Procedure.

Journal: Kidney international reports

Published: December 31, 2019

Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 13, 2019

IgA Nephropathy in Elderly Patients.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 11, 2018

Treatment with bortezomib in dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Journal: British journal of haematology

Published: January 25, 2018